| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | EVP, Chief Strategy Officer | $15.3M | May 16, 2022 | ||
| NMRA | Neumora Therapeutics, Inc. | President & CEO, Director | $7.07M | Feb 14, 2024 | ||
| SLRN | ACELYRIN, Inc. | Director | $0 | May 21, 2025 | ||
| APTX | Aptinyx Inc. | Director | May 26, 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|